XIST was selected in the male vs. female classification model for 14 of 17 cancer types, but was not selected in any of the male vs. female analyses in normal samples, suggesting that differences in XIST expression between male and female tissues emerge during oncogenesis. The gene discussed is XIST; the disease is cancer.